Dynavax Technologies Corporation (DVAX)

Exchange
NASDAQ
Symbol
DVAX
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company is headquartered in Emeryville, California.
Country
USA

Stock price

At close: January 7, 2026

  • Open
    15.43
  • High
    15.45
  • Low
    15.40
  • Close
    15.41
  • Volume
    2,741,650

Financial ratios

Dec 31, 2024